137 related articles for article (PubMed ID: 9360756)
1. Reduction of soluble ICAM-1 levels in nasal secretion by H1-blockers in seasonal allergic rhinitis.
Campbell A; Chanal I; Czarlewski W; Michel FB; Bousquet J
Allergy; 1997 Oct; 52(10):1022-5. PubMed ID: 9360756
[TBL] [Abstract][Full Text] [Related]
2. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
[TBL] [Abstract][Full Text] [Related]
3. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.
Ciprandi G; Tosca M; Ricca V; Passalacqua G; Riccio AM; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1160-6. PubMed ID: 9383256
[TBL] [Abstract][Full Text] [Related]
4. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
[TBL] [Abstract][Full Text] [Related]
5. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
[No Abstract] [Full Text] [Related]
6. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
7. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
8. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis.
Frossard N; Lacronique J; Melac M; Benabdesselam O; Braun JJ; Glasser N; Pauli G
Allergy; 1997 Feb; 52(2):205-9. PubMed ID: 9105526
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.
Pullerits T; Praks L; Ristioja V; Lötvall J
J Allergy Clin Immunol; 2002 Jun; 109(6):949-55. PubMed ID: 12063523
[TBL] [Abstract][Full Text] [Related]
10. Changes in skin-test reactivity do not correlate with clinical efficacy of H1-blockers in seasonal allergic rhinitis.
Bousquet J; Czarlewski W; Cougnard J; Danzig M; Michel FB
Allergy; 1998 Jun; 53(6):579-85. PubMed ID: 9689339
[TBL] [Abstract][Full Text] [Related]
11. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
[TBL] [Abstract][Full Text] [Related]
12. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
13. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
Day JH; Briscoe M; Rafeiro E; Chapman D; Kramer B
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
[TBL] [Abstract][Full Text] [Related]
14. Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis.
Frossard N; Benabdesselam O; Melac M; Glasser N; Lacronique J; Pauli G
Am J Ther; 1998 Sep; 5(5):307-11. PubMed ID: 10099074
[TBL] [Abstract][Full Text] [Related]
15. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
Ciprandi G; Tosca MA; Milanese M; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
17. [Antihistaminics. Side effects also after raising dosage at the placebo level].
MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children.
Simons FE; Johnston L; Simons KJ
Pediatr Allergy Immunol; 2000 May; 11(2):116-9. PubMed ID: 10893015
[TBL] [Abstract][Full Text] [Related]
19. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy.
Ciprandi G; Pronzato C; Ricca V; Varese P; Del Giacco GS; Canonica GW
Clin Exp Allergy; 1995 Sep; 25(9):871-8. PubMed ID: 8564726
[TBL] [Abstract][Full Text] [Related]
20. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis.
Kaszuba SM; Baroody FM; deTineo M; Haney L; Blair C; Naclerio RM
Arch Intern Med; 2001 Nov; 161(21):2581-7. PubMed ID: 11718589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
